Angiosarcoma of the thoracic wall responded well to nanoparticle albumin-bound paclitaxel: A case report

11Citations
Citations of this article
17Readers
Mendeley users who have this article in their library.

Abstract

An 81-year-old woman visited a local clinic due to chest pain and a skin induration on the right precordia. She had a history of right breast cancer, and she had undergone a mastectomy and radiation therapy 10 years prior. Computed tomography (CT) imaging of the chest demonstrated a lobular mass that involved the right anterior thoracic wall and partially extruded from the thoracic cavity into the subcutaneous tissue. The tumor was surgically excised, and pathological analyses yielded a diagnosis of angiosarcoma. Five months after the operation, CT imaging showed multiple masses on the right pleura, indicating a local relapse and pleural dissemination of the angiosarcoma. Systemic chemotherapy composed of nanoparticle albumin-bound paclitaxel (nab-PTX) (80 mg/m(2)) was delivered weekly. After 4 courses of chemotherapy, the tumors regressed remarkably. Nab-PTX may be an effective treatment option for recurrent or metastatic angiosarcoma.

Cite

CITATION STYLE

APA

Hara, N., Fujimoto, N., Miyamoto, Y., Yamagishi, T., Asano, M., Fuchimoto, Y., … Kishimoto, T. (2016). Angiosarcoma of the thoracic wall responded well to nanoparticle albumin-bound paclitaxel: A case report. Drug Discoveries & Therapeutics, 10(2), 114–116. https://doi.org/10.5582/ddt.2016.01005

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free